ZA201508530B - Pyrazolopyridine derivatives for use in the treatment of bladder cancer - Google Patents

Pyrazolopyridine derivatives for use in the treatment of bladder cancer

Info

Publication number
ZA201508530B
ZA201508530B ZA2015/08530A ZA201508530A ZA201508530B ZA 201508530 B ZA201508530 B ZA 201508530B ZA 2015/08530 A ZA2015/08530 A ZA 2015/08530A ZA 201508530 A ZA201508530 A ZA 201508530A ZA 201508530 B ZA201508530 B ZA 201508530B
Authority
ZA
South Africa
Prior art keywords
treatment
bladder cancer
pyrazolopyridine derivatives
pyrazolopyridine
derivatives
Prior art date
Application number
ZA2015/08530A
Inventor
Chantal Alcouffe
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2014/062459 external-priority patent/WO2015188886A1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA201508530B publication Critical patent/ZA201508530B/en

Links

ZA2015/08530A 2013-06-14 2015-11-18 Pyrazolopyridine derivatives for use in the treatment of bladder cancer ZA201508530B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1355578 2013-06-14
PCT/EP2014/062459 WO2015188886A1 (en) 2014-06-13 2014-06-13 Hybrid automatic repeat request for enhanced interference management and traffic adaptation

Publications (1)

Publication Number Publication Date
ZA201508530B true ZA201508530B (en) 2017-03-29

Family

ID=60934876

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/08530A ZA201508530B (en) 2013-06-14 2015-11-18 Pyrazolopyridine derivatives for use in the treatment of bladder cancer

Country Status (1)

Country Link
ZA (1) ZA201508530B (en)

Similar Documents

Publication Publication Date Title
IL283943B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k related disorders
IL268094B (en) Derivatives of hetrerocyclic compounds for use in the treatment of lung cancer
PL3007694T3 (en) Pyrazolopyridine derivatives for use in the treatment of bladder cancer
HRP20180876T1 (en) Duocarmycin adcs for use in the treatment of bladder cancer
IL246239B (en) Bicyclic heterocycle compounds and their uses in therapy
IL251630A0 (en) Combination therapy for use in cancer therapy
IL276733A (en) Use of eribulin in the treatment of cancer
EP3733184C0 (en) Pyrimidine compounds for use in the treatment of cancer
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
SI2872176T1 (en) Carboranylporphyrins for use in the treatment of cancer
IL233493A (en) Imidazopyridine derivatives for the treatment of cancer
ZA201508530B (en) Pyrazolopyridine derivatives for use in the treatment of bladder cancer
EP3104863C0 (en) Salicylates for use in the treatment of cancer
GB201322755D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201322958D0 (en) Uses of oligouronates in cancer treatment